Pain In Psychiatric Disorders

This book offers a series of authoritative reviews on pain in psychiatric disorders written by leading experts. They discuss the complex interplay between pain and psychiatric disorders such as anxiety, depression and borderline personality disorder, as well as neurosteroids, epigenetic mechanisms and TRPV1, with a strong focus on neurobiological mechanisms and current and future therapeutic targets. Special attention is given to the importance of inflammation and the immune system as a common substrate in both pain and psychiatric disorders. The state-of-the-art reviews present both preclinical and clinical research, providing the reader with sound knowledge that provides a basis for further research and clinical practice. Pain in Psychiatric Disorders is of special interest to psychiatrists, neurologists, neuroscientists, pharmacologists and other healthcare professionals treating pain in psychiatric patients, as well as research students with an interest in this field.

Chronic pain seldom presents alone. Pain patients frequently have comorbid psychiatric conditions and those suffering from mental illness often experience pain. Nonetheless, pain conditions and psychiatric disorders have customarily been understood and treated as different and separate clinical entities, to the detriment of patients' wellbeing. This book will describe the complex and striking relationships between pain and psychiatric disorders, offering the first comprehensive review of the challenging and neglected intersection between pain medicine and psychiatry. Written by world-renowned experts in the fields of pain and psychiatry, chapters contribute a valuable array of clinical and theoretical perspectives and include illustrative case examples throughout.

Under certain pathological conditions, the pain processing system, which includes both physiological and psychological components, can produce the experience of pain in the absence of any peripheral noxious event. Considerable evidence now indicates that alterations in pain perception are characteristic of many clinical pain states. Pathophysiology of Pain Perception primarily examines these pathological alterations in the pain-signaling system, with contributions from leading researchers in the field focusing on the functioning of the pain processing system under normal and pathological conditions. The understanding of pain perception is essential for optimal diagnosis and treatment of acute and chronic pain. This book covers the basics of pain perception (peripheral and central neurotransmission, methods of assessment), various pathological (chronic pain conditions, neurological and psychiatric diseases, cardiovascular disease), and non-pathological alterations of pain perception (pregnancy, labor) as well as the treatments aiming at influencing pain perception such as pharmacological, physical and psychological treatments.

Painâ€"it is the most common complaint presented to physicians. Yet pain is subjectiveâ€"it cannot be measured directly and is difficult to validate. Evaluating claims based on pain poses major problems for the Social Security Administration (SSA) and other disability insurers. This volume covers the epidemiology and physiology of pain; psychosocial contributions to pain and illness behavior; promising ways of assessing and measuring chronic pain and dysfunction; clinical aspects of prevention, diagnosis, treatment, and rehabilitation; and how the SSA's benefit structure and administrative procedures may affect pain complaints.

Bringing together treatment and referral advice from existing guidelines, this text aims to improve access to services and recognition of common mental health disorders in adults and provide advice on the principles that need to be adopted to develop appropriate referral and local care pathways.

Since the original publication of this landmark volume, tremendous advances have been made in understanding and managing psychological factors in pain. This revised and greatly expanded second edition now brings the field fully up to date. Designed for maximum clinical utility, the text shows how to tailor psychological treatment programs to patients suffering from a wide range of pain problems. Conceptual and diagnostic issues are discussed, widely used clinical models reviewed, and a framework presented for integrating psychological treatment with medical and surgical interventions. The second edition has been augmented with detailed case material and the latest treatment outcomes data. Thirteen entirely new chapters provide coverage of specific pain syndromes and disorders, as well as interventions for pain-related fear and preparing patients for implantable technologies.

The Clinical Manual of Pain Management in Psychiatry focuses on the role of mental health practitioners in evaluation and assessment, pharmacological management, psychotherapeutic interventions, and comprehensive treatment planning for pain. It balances theoretical foundations of pain pathophysiology with applied clinical information, all the while viewing the patient from biological, psychological, and social perspectives in order to tailor treatment to the whole person. This handy portable guide includes numerous tables and illustrations and expands on the author's previous Concise Guide to Pain Management for Psychiatrists to reflect significant advances in the field of pain medicine. It features particularly extensive revisions regarding the use of psychiatric and other adjunctive medications in pain management; includes updated coverage of common psychiatric comorbidities such as depression, anxiety, and personality disorders; and addresses common pain disorders ranging from headache and back pain to pain related to cancer and HIV. The manual includes an extensively revised chapter on pharmacology, fully discusses psychotherapeutic approaches, and covers special techniques such as acupuncture and regional neural blockade. It also offers updated advice on emerging forensic issues, from disability claims to controlled substance diversion.

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.